Cardiovascular Therapies and Associated Glucose Homeostasis Implications Across the Dysglycemia Continuum

被引:38
作者
Cooper-DeHoff, Rhonda M. [1 ]
Pacanowski, Michael A. [2 ,3 ]
Pepine, Carl J. [1 ]
机构
[1] Univ Florida, Coll Med, Div Cardiovasc Med, Gainesville, FL 32610 USA
[2] Univ Florida, Dept Pharm Practice, Gainesville, FL 32610 USA
[3] Univ Florida, Ctr Pharmacogenom, Coll Pharm, Gainesville, FL 32610 USA
关键词
IMPAIRED FASTING GLUCOSE; LIPID-LOWERING TREATMENT; ANGIOTENSIN RECEPTOR BLOCKERS; HEALED MYOCARDIAL-INFARCTION; TYPE-2; DIABETES-MELLITUS; CORONARY-ARTERY-DISEASE; METABOLIC SYNDROME; INSULIN-RESISTANCE; CLINICAL-OUTCOMES; ANTIHYPERTENSIVE TREATMENT;
D O I
10.1016/j.jacc.2008.10.037
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Certain cardiovascular drugs have adverse effects on glucose homeostasis, which may lead to important long-term implications for increased risks of adverse outcomes. Thiazide diuretics, niacin, and beta-adrenergic blockers impair glucose homeostasis. However, angiotensin-converting enzyme inhibitors and angiotensin receptor blockers have demonstrated beneficial metabolic effects. The newer vasodilating beta-blocking agents and calcium antagonists appear to be metabolically neutral. These considerations, in addition to meticulous attention to blood pressure control and lifestyle changes, have the potential to beneficially modify glycemia and long-term risks. These considerations have particular importance in younger patients who may also have pre-diabetes or the metabolic syndrome and who are likely to require therapy over the course of decades. (J Am Coll Cardiol 2009;53:S28-34) (C) 2009 by the American College of Cardiology Foundation
引用
收藏
页码:S28 / S34
页数:7
相关论文
共 75 条
[61]   High risk of cardiovascular mortality in individuals with impaired fasting glucose is explained by conversion to diabetes - The Hoorn Study [J].
Rijkelijkhuizen, Josina M. ;
Bouter, Lex M. ;
Nijpels, Giel ;
Stehouwer, Coen D. A. ;
Heine, Robert J. ;
Dekker, Jacqueline M. .
DIABETES CARE, 2007, 30 (02) :332-336
[62]   New hypertension guidelines from the National Institute for Health and Clinical Excellence and the British Hypertension Society [J].
Sever, Peter .
JOURNAL OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM, 2006, 7 (02) :61-63
[63]   Incidence of type 2 diabetes in the randomized multiple risk factor intervention trial [J].
Smith, GD ;
Bracha, Y ;
Svendsen, KH ;
Neaton, JD ;
Haffner, SM ;
Kuller, LH .
ANNALS OF INTERNAL MEDICINE, 2005, 142 (05) :313-322
[64]   Abdominal Obesity Is Associated With Potassium Depletion and Changes in Glucose Homeostasis During Diuretic Therapy [J].
Souza Mariosa, Lydia Sebba ;
Ribeiro-Filho, Fernando Flexa ;
Batista, Marcelo Costa ;
Hirota, Andrea Harumi ;
Borges, Rodolfo Leao ;
Ribeiro, Artur Beltrame ;
Zanella, Maria Teresa .
JOURNAL OF CLINICAL HYPERTENSION, 2008, 10 (06) :443-449
[65]   The psychology of decision making in a unified behavioral science [J].
Stanovich, Keith E. .
BEHAVIORAL AND BRAIN SCIENCES, 2007, 30 (01) :41-+
[66]   Effects of ranolazine on exercise tolerance and HbA1c in patients with chronic angina and diabetes [J].
Timmis, AD ;
Chaitman, BR ;
Crager, M .
EUROPEAN HEART JOURNAL, 2006, 27 (01) :42-48
[67]   Adverse prognostic significance of new diabetes in treated hypertensive subjects [J].
Verdecchia, P ;
Reboldi, G ;
Angeli, F ;
Borgioni, C ;
Gattobigio, R ;
Filippucci, L ;
Norgiolini, S ;
Bracco, C ;
Porcellati, C .
HYPERTENSION, 2004, 43 (05) :963-969
[68]   New-onset diabetes, antihypertensive treatment, and outcome [J].
Verdecchia, Paolo ;
Angeli, Fabio ;
Reboldi, Gianpaolo .
HYPERTENSION, 2007, 50 (03) :459-460
[69]   Niacin plus simvastatin reduces coronary stenosis progression among patients with metabolic syndrome despite a modest increase in insulin resistance: A subgroup analysis of the HDL-Atherosclerosis treatment study [J].
Vittone, Francesca ;
Chait, Alan ;
Morse, Josh S. ;
Fish, Brian ;
Brown, B. Greg ;
Zhao, Xue-Qiao .
JOURNAL OF CLINICAL LIPIDOLOGY, 2007, 1 (03) :203-210
[70]   Should diabetes be considered a coronary heart disease risk equivalent? Results from 25 years of follow-up in the Renfrew and Paisley Survey [J].
Whiteley, L ;
Padmanabhan, S ;
Hole, D ;
Isles, C .
DIABETES CARE, 2005, 28 (07) :1588-1593